CLINICAL TRIAL
Published on 28 Jul 2022
A randomized triple-blind controlled clinical trial evaluation of sitagliptin in the treatment of patients with non-alcoholic fatty liver diseases without diabetes
doi 10.3389/fmed.2022.937554
- 3,492 views
- 9 citations